The Inhibitory Function in Human Progesterone Receptor N Termini Binds SUMO-1 Protein to Regulate Autoinhibition and Transrepression
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Although most studies of progesterone receptors (PR) and their two isoforms, PR-A and PR-B, focus on transcriptional stimulation, the receptors exhibit important inhibitory properties. Autoinhibition refers to an inhibitory function located in the PR N terminus, whose deletion increases transcriptional activity at least 6-10-fold. Transrepression refers to the ability of PR-A to suppress the transcriptional activity of PR-B and other nuclear receptors, including estrogen receptors. Self-squelching refers to the observation in transient transfection assays that increasing receptor concentrations paradoxically decrease transcriptional activity. Using a series of N-terminal deletion mutants constructed in both PR isoforms, we have mapped their autoinhibitory and transrepressor activities to a small ubiquitin-like modifier (SUMO-1) protein consensus-binding motif, (387)IKEE, located in the N terminus upstream of AF1. Self-squelching does not involve this site. SUMO-1 binds PR covalently at (387)IKEE, but only if the C-terminal, liganded, hormone-binding domain is also present. A single point K388R mutation within the (387)IKEE motif in either PR-A or PR-B leads to a loss of autoinhibitory and transrepressor functions of the liganded, full-length receptors. We conclude that autoinhibition and transrepression involve N-terminal sumoylation combined with intramolecular N/C-terminal communication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kastner, P., Krust, A., Turcotte, B., Stropp, U., Tora, L., Gronemeyer, H., & Chambon, P. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08280.x · Cited by 1,534
Cited by
Johnson, E. S. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.074118 · Cited by 1,675
SUMO and ubiquitin in the nucleus: different functions, similar mechanisms?
Gill, G. (2004) · Genes & Development · doi:10.1101/gad.1214604 · Cited by 756
Nuclear and unclear functions of SUMO
Seeler, J.-S., & Dejean, A. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1200 · Cited by 667
Decidualization of the Human Endometrium: Mechanisms, Functions, and Clinical Perspectives
Gellersen, B., Brosens, I., & Brosens, J. (2007) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-991042 · Cited by 587
Modification with SUMO: A role in transcriptional regulation
Verger, A., Perdomo, J., & Crossley, M. (2003) · EMBO reports · doi:10.1038/sj.embor.embor738 · Cited by 440
Cyclic AMP and progesterone receptor cross-talk in human endometrium: a decidualizing affair
Gellersen, B., & Brosens, J. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1780357 · Cited by 436
Nuclear Receptor Structure: Implications for Function
Bain, D. L., Heneghan, A. F., Connaghan-Jones, K. D., & Miura, M. T. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.031905.160308 · Cited by 366
SUMO‐targeted ubiquitin ligases in genome stability
Prudden, J., Pebernard, S., Raffa, G., Slavin, D. A., Perry, J. J. P., Tainer, J. A., McGowan, C. H., & Boddy, M. N. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601838 · Cited by 335
PIAS/SUMO: new partners in transcriptional regulation
Schmidt, D., & M�ller, S. (2003) · Cellular and Molecular Life Sciences (CMLS) · doi:10.1007/s00018-003-3129-1 · Cited by 284
SUMO: a regulator of gene expression and genome integrity
Müller, S., Ledl, A., & Schmidt, D. (2004) · Oncogene · doi:10.1038/sj.onc.1207415 · Cited by 283
Novel concepts on pregnancy clocks and alarms: redundancy and synergy in human parturition
Menon, R., Bonney, E. A., Condon, J., Mesiano, S., & Taylor, R. N. (2016) · Human Reproduction Update · doi:10.1093/humupd/dmw022 · Cited by 261
The Mineralocorticoid Receptor: A Journey Exploring Its Diversity and Specificity of Action
Pascual-Le Tallec, L., & Lombès, M. (2005) · Molecular Endocrinology · doi:10.1210/me.2005-0089 · Cited by 257
Progesterone: Therapeutic opportunities for neuroprotection and myelin repair
Schumacher, M., Guennoun, R., Stein, D. G., & De Nicola, A. F. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.06.001 · Cited by 246
“Moreover, in a promoter-and cell-specific manner, PR-A has been shown to repress the transcriptional activity of PR-B and the other steroid receptors, an effect which has been qualified as “ transrepression ” (Vegeto et al., 1993; Wen et al., 1994; Kraus et al., 1995; Abdel-Hafiz et al., 2002).”
Lavery, D. N., & Mcewan, I. J. (2005) · Biochemical Journal · doi:10.1042/bj20050872 · Cited by 227
Progesterone: the ultimate endometrial tumor suppressor
Yang, S., Thiel, K. W., & Leslie, K. K. (2011) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2011.01.005 · Cited by 194
“PR possesses a single consensus Ψ KXE SUMO-conjugation motif (where Ψ is a large hydrophobic residue and X is any residue) in its N-terminus that is conserved in both isoforms [64,72].”
BackgroundProgesterone action in breast, uterine, and ovarian cancers
Diep, C. H., Daniel, A. R., Mauro, L. J., Knutson, T. P., & Lange, C. A. (2015) · Journal of Molecular Endocrinology · doi:10.1530/jme-14-0252 · Cited by 190
“Differential signaling and transcriptional activities of the isoforms as well as altered ability of PR-A to transrepress other steroid receptors probably contribute to breast pathologies (Abdel-Hafiz et al. 2002).”
BackgroundMechanisms of endometrial progesterone resistance
Al-Sabbagh, M., Lam, E. W.-F., & Brosens, J. J. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.10.035 · Cited by 183
Selective Progesterone Receptor Modulators—Mechanisms and Therapeutic Utility
Islam, M. S., Afrin, S., Jones, S. I., & Segars, J. (2020) · Endocrine Reviews · doi:10.1210/endrev/bnaa012 · Cited by 143
“phosphorylation (45), ubiquitination (46), and sumoylation (47) that serve to influence their stability, trafficking, transcriptional activity, and target gene selectivity.”
BackgroundNuclear receptor coactivators: structural and functional biochemistry
Bulynko, Y. A., & O’Malley, B. W. (2011) · Biochemistry · doi:10.1021/bi101762x · Cited by 113
Kurihara, I., Shibata, H., Kobayashi, S., Suda, N., Ikeda, Y., Yokota, K., Murai, A., Saito, I., Rainey, W. E., & Saruta, T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411820200 · Cited by 46
Metadata
- Authors
- Abdel-Hafiz, H., Takimoto, G. S., Tung, L., & Horwitz, K. B.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-09
- Volume
- 277
- Issue
- 37
- Pages
- 33950-33956
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W1965959528
- Cited by
- 149
- References
- 1
- FWCI
- 6.34
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.